COMMISSION IMPLEMENTING REGULATION (EU) No 1090/2014
of 16 October 2014
approving permethrin as an existing active substance for use in biocidal products for product-types 8 and 18
(Text with EEA relevance)
Article 1
Article 2
ANNEX
Common Name |
IUPAC Name Identification Numbers |
Minimum degree of purity of the active substance(1) |
Date of approval |
Expiry date of approval |
Product type |
Specific conditions(2) |
||||||||
Permethrin |
IUPAC Name: 3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate EC No: 258-067-9 CAS No: 52645-53-1 The cis:trans ratio is 25:75. |
930 g/kg |
1 May 2016 |
30 April 2026 |
8 |
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. For biocidal products, authorisations are subject to the following conditions:
For treated articles, the following condition applies: Where a treated article has been treated with or intentionally incorporates permethrin, and where necessary due to the possibility of skin contact as well as the release of permethrin under normal conditions of use, the person responsible for placing the article on the market shall ensure that the label provides information on the risk of skin sensitisation, as well as the information referred to in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012. |
||||||||
18 |
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. For biocidal products, authorisations are subject to the following conditions:
For treated articles, the following condition applies: Where a treated article has been treated with or intentionally incorporates permethrin, and where necessary due to the possibility of skin contact as well as the release of permethrin under normal conditions of use, the person responsible for placing the article on the market shall ensure that the label provides information on the risk of skin sensitisation, as well as the information referred to in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012. |